¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ - Á¦Ç°º°, ¼­ºñ½ºº°, À§»óº°, Áö¿ªº° ½ÃÀå ¿¹Ãø(2024-2032³â)
Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product, By Service, By Phase, and By Region - Market Forecast, 2024-2032
»óǰÄÚµå : 1566345
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 116 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,112,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,551,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,989,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 80¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀº ÀÓ»ó½ÃÇè Áß¿¡ ¼öÁýµÈ »ý¹°ÇÐÀû »ùÇà ¹× µ¥ÀÌÅÍÀÇ º¸°ü, °ü¸®, º¸Á¸À» À§ÇÑ ¼­ºñ½º ¹× ±â¼úÀ» Á¦°øÇÏ´Â ÀÇ·á ¹× »ý¸í°úÇÐ »ê¾÷ ºÐ¾ß¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â Ç÷¾×, Á¶Á÷, DNA ¹× ±âŸ »ý¹°ÇÐÀû ¹°Áú°ú °°Àº »ùÇÃÀ» ó¸®Çϰí ÇâÈÄ ¿¬±¸ ¹× ºÐ¼®À» À§ÇØ ¿ÏÀü¼º°ú °¡¿ë¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¼³°èµÈ ´Ù¾çÇÑ ¼Ö·ç¼ÇÀÌ Æ÷ÇԵ˴ϴÙ. ÀǾàǰ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í »ý¹°ÇÐÀû ½Ã·áÀÇ È¿À²ÀûÀÎ °ü¸®¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀÌ À̾îÁö°í ÀÖ½À´Ï´Ù. ±âŸ ¼¼°è ÀÓ»ó½ÃÇè Áõ°¡, ¹ÙÀÌ¿À¹ðÅ· ±â¼ú Áøº¸, µ¥ÀÌÅÍ ¹«°á¼º ¹× »ùÇà º¸Á¸¿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°Ç Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °æ»ç Áõ°¡, À¯Àüü ¿¬±¸¿¡ ´ëÇÑ °ü½É Áõ°¡, »ùÇà ÃßÀû ¹× ºÐ¼®À» À§ÇÑ AI¿Í ÀÚµ¿È­ÀÇ ÅëÇÕÀº ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå¿¡ ¾öû³­ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ½ÃÀå¿¡¼­´Â Áß¾Ó ÁýÁᫎ ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮¿Í Ŭ¶ó¿ìµå ±â¹Ý ¾ÆÄ«ÀÌºê ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀÌ ÁøÇàµÇ°í ÀÖ¾î Á¢±Ù¼º°ú Çù¾÷ÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÀÓ»ó½ÃÇèÀÇ º¹À⼺°ú ´Ù¾çÇÑ ¿¬±¸°³¹ß°ú Ä¡·á°³¹ßÀ» Áö¿øÇÏ´Â °ß°íÇÑ ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ÀÎÇÁ¶óÀÇ Çʿ伺À¸·Î ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦Ç°º°·Î, ÀÓ»ó Á¦Ç° ºÐ¾ß´Â ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÓ»ó½ÃÇè °Ç¼ö Áõ°¡¿Í ÀǾàǰ °³¹ßÀÇ ´Ù¾çÇÑ ´Ü°è¿¡¼­ÀÇ °íǰÁú »ùÇà °ü¸®¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.

¼­ºñ½ºº°·Î´Â »ý¹° ½Ã·áÀÇ º¸°ü ¹× °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¼­ºñ½º°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

ÆäÀÌÁ·Î´Â ÆäÀÌÁî III°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸À̰í ÀÖÁö¸¸, ÀÌ´Â À¯¸ÁÇÑ ½Å¾à È常¦ ±â¾÷ÀÌ ½ÃÀå ½ÂÀΰú »ó¾÷È­¸¦ ÇâÇØ ÁøÇàÇÏ´Â °¡¿îµ¥, ÀÌ ´Ü°è¿¡¼­ÀÇ ÀÓ»ó½ÃÇè ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù.

ºÏ¹Ì´Â ±¤¹üÀ§ÇÑ ÀÓ»ó ¿¬±¸ ÀÎÇÁ¶ó¿Í ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÅëÇØ ¼¼°è ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÅÈï±¹¿¡¼­ÀÇ ÀÓ»ó½ÃÇè ±ÞÁõ°ú ¹ÙÀÌ¿À¸®Æ÷ÁöÅ丮 ÅõÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå ¼ºÀåÇϰí ÀÖ´Â Áö¿ªÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ¼¼°è ½ÃÀå ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : ¼­ºñ½ºº°

Á¦7Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå : ´Ü°èº°

Á¦8Àå ¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ¹ÙÀÌ¿À ¸®Æ÷ÁöÅ丮 ¹× ¾ÆÄ«ÀÌºê ¼Ö·ç¼Ç ½ÃÀå :Áö¿ª

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 8.09 billion by 2032, according to a new study by Polaris Market Research. The report "Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product (Preclinical Products and Clinical Products), By Service, By Phase, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The clinical trial biorepository & archiving solutions market refers to the sector of the healthcare and life sciences industry that provides services and technologies for the storage, management, and preservation of biological samples and data collected during clinical trials. This market includes a range of solutions designed to handle samples such as blood, tissue, DNA, and other biological materials, ensuring their integrity and availability for future research and analysis. Increasing investments in drug development and growing need for efficient management of biological samples drive the clinical trial biorepository & archiving solutions market growth. Other factors such as a rise in clinical trials globally, advancements in biobanking technologies, and increase in regulatory requirements for data integrity and sample storage propel the market growth.

Rising inclination toward personalized medicine, increasing focus on genomic research, and the integration of AI and automation for sample tracking and analysis would provide vast opportunities for the market in the coming years. Emerging in the market are a shift toward centralized biorepositories and cloud-based archiving solutions, enhancing accessibility and collaboration. Overall, the market is expected to grow significantly, driven by the increasing complexity of clinical trials and the need for robust biorepository infrastructure to support diverse research and therapeutic developments.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights

By product, the clinical products segment dominates the clinical trial biorepository & archiving solutions market, driven by the increasing number of clinical trials and the rising need for high-quality sample management across various stages of drug development.

The biorepository services dominate the market, based on service type, due to their critical role in the storage and management of biological samples, essential for the growing number of clinical and research studies requiring extensive sample archiving.

In terms of phase, the phase III segment is witnessing the highest growth rate, reflecting the increasing number of trials in this phase as companies advance promising drug candidates toward market approval and commercialization.

North America dominates the global clinical trial biorepository & archiving solutions market, owing to its extensive clinical research infrastructure and investments in biorepository solutions. However, Asia Pacific is the highest growing region, driven by a surge in clinical trials and increase in biorepository investments in emerging economies.

Polaris Market Research has segmented the clinical trial biorepository & archiving solutions market report on the basis of product, service, phase, and region.

Clinical Trial Biorepository & Archiving Solutions, Product Outlook (Revenue - USD Billion, 2019-2032)

Clinical Trial Biorepository & Archiving Solutions, Service Outlook (Revenue - USD Billion, 2019-2032)

Clinical Trial Biorepository & Archiving Solutions, Phase Outlook (Revenue - USD Billion, 2019-2032)

Clinical Trial Biorepository & Archiving Solutions, Regional Outlook (Revenue - USD Billion, 2019-2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Clinical Trial Biorepository & Archiving Solutions Market Insights

5. Global Clinical Trial Biorepository & Archiving Solutions Market, by Product

6. Global Clinical Trial Biorepository & Archiving Solutions Market, by Service Type

7. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase

8. Global Clinical Trial Biorepository & Archiving Solutions Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â